ArticleArchives of dermatological research2024
Association between atopic dermatitis with hyperparathyroidism not mediated by vitamin D in the United States (NHANES 2005-2006).
Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- A Cost-Effective Screening Inflammation Indicator for Atopic Dermatitis Suitable for Primary Care and Self-Assessment.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between atopic eczema and hyperparathyroidism remains doubtful. Participants with atopic dermatitis have lower serum vitamin D levels. Whether it is mediated by vitamin D or other potential factors remains uncertain as well. This study aims to determine the impact of AD on hyperparathyroidism and the direct mediators. A total of 7266 subjects in the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2006 were included in this study. Diagnoses of AD were based on questionnaire answering. Hyperparathyroidism was assessed by biochemical examination. Weighted logistic regression analysis reported odds ratios (ORs), and mediation analysis was applied to evaluate the mediating effect. Subgroup analysis stratified by age and vitamin D level was further performed after the confirmation of the association. Participants with AD had higher odds of developing hyperparathyroidism (OR [95% CI], 1.86 [1.040, 3.326], P = 0.041). The association was not mediated by vitamin D or other potential factors, including calcium, phosphorus, BMI and CRP. Otherwise, subgroup analysis demonstrated that the association exhibited variations based on age and vitamin D level, especially in subjects older than 60 years old and with normal vitamin D levels. Participants with AD are inclined to have hyperparathyroidism. We recommend a more rigorous focus on hyperparathyroidism in patients with AD, especially those over 60 years of age and with normal serum vitamin D levels.
Indexed as
Identifiers
39666073What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.